You are viewing the site in preview mode

Skip to main content

Advertisement

Table 4 Patients’ characteristics and baseline parameters with and without cultivated Enterococcus spp.

From: The role of Enterococcus spp. and multidrug-resistant bacteria causing pyogenic liver abscesses

Characteristics Patient with Enterococcus isolates (n = 37) Patient without Enterococcus isolates (n = 41)a P
Age, y 65 (56–72) 55 (50–70) 0.168
Duration of hospitalization, days 23 (14–37) 18 (9–30) 0.123
Biliary cause of PLA, n (%) 28 (75.7) 21 (35.0) 0.035
Malignancy, n (%) 16 (43.2) 14 (35.0) 0.491
Liver cirrhosis, n (%) 7 (18.9) 6 (15.0) 0.764
Diabetes mellitus, n (%) 11 (29.7) 9 (22.5) 0.604
Cholangitis, n (%) 20 (54.1) 17 (42.5) 0.365
Intake of immunosuppressants, n (%) 7 (18.9) 7 (17.5) 1.000
Intake of proton-pump inhibitors, n (%) 32 (86.5) 26 (65.0) 0.036
Previous known MDRO, n (%) 11 (29.7) 4 (10.0) 0.043
Previous admission <3 month, n (%) 35 (94.6) 30 (75.0) 0.026
Previous ICU admission <3 month, n (%) 11 (29.7) 6 (15.0) 0.170
Previous surgical/endoscopic Intervention
 Previous endoscopic Intervention, n (%) 29 (78.4) 22 (55.0) 0.053
 Previous ERCP/PTCD, n (%) 29 (78.4) 17 (42.5) 0.002
 ERCP/PTCD <3 month, n (%) 27 (73.0) 16 (40.0) 0.006
 Laid-in biliary stent, n (%) 23 (62.2) 13 (32.5) 0.012
 History of abdominal surgery, n (%) 28 (75.7) 17 (42.5) 0.005
 Abdominal surgery <6 month, n (%) 16 (43.2) 12 (30.0) 0.246
Laboratory results
 C-reactive protein (mg/dl) 11.2 (6.2–14.7) 11.1 (8.9–18.0) 0.266
 White blood count (/nl) 10.3 (7.0–17.9) 12.6 (9.2–16.2) 0.580
 International normalized ratio 1.3 (1.1–1.5) 1.3 (1.2–1.4) 0.899
 Creatinine (mg/dl) 0.81 (0.62–1.23) 0.79 (0.57–0.93) 0.303
 Albumin (g/dl) 2.7 (2.1–3.2) 2.8 (2.4–3.0) 0.647
 Aspartate aminotransferase (U/l) 68 (28–136) 44 (26–96) 0.365
 Alanine aminotransferase (U/l) 40 (20–75) 37 (19–74) 0.947
 γ-Glutamyltransferase (U/l) 202 (136–403) 203 (92–534) 0.828
 Alkaline phosphatase (UI/l) 239 (143–401) 221 (138–432) 0.859
 Bilirubin (mg/dl) 1.0 (0.6–5.2) 1.0 (0.6–3.6) 0.719
  1. Data are presented as media (IQR) unless otherwise indicated
  2. Abbreviations: ERCP endoscopic retrograde cholangiopancreatography, PTCD percutaneous transhepatic cholangiography and drainage
  3. aPatients without bacterial isolates were excluded